TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/19/2025ACC: 0001601830-25-000133
Officer· Chief Financial Officer
Since Feb 2026
-11.91K
Net shares
Net seller
$67.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.91K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−11.91K
Price / share
$5.64
Trade value
$67.16K
% of position
1.4%
8/15/2025
823.13K→811.23K
Total
Net shares
−11.91K
Net value
-$67.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/15/2025 | F · Tax Withholding | −11.91K | $5.64 | $67.16K | 1.4% | 823.13K | 811.23K |
| Total | −11.91K | -$67.16K | ||||||
Derivative Transactions0
No derivative transactions reported